| Announcements
Lyndsay Harris to Co-Lead Genetics and Genomics Program with Frank Slack I am please so announce that Lyndsay Harris will co-direct the Yale Cancer Center Genetics and Genomics Research Program , along with Frank Slack.
Lyndsay's leadership and clinical research experience will be an asset to the program as we continue to strengthen our inter- and intra-programmatic research efforts. She has made crucial contributions to our understanding of the biology and treatment of breast cancer, which continue to positively impact the care of our patients.
Closer to Free Two new Smilow Cancer Hospital Closer to Free television commercials are now in rotation on all Connecticut network television stations, as well as certain cable stations across the state.
Both spots are also uploaded to the Yale-New Haven YouTube page. I encourage you to visit the YouTube channel and forward the link to colleagues and friends to view the spots.
Learn More >>
Smilow Town Hall I look forward to seeing all of you at our Smilow Cancer Hospital Town Hall meeting on Wednesday, March 2 at 11:30 AM in the auditorium at 55 Park Street. Abe Lopman, Cathy Lyons, Peter Marks, and I will be sharing the latest information on goals and operations at Smilow. We also welcome your suggestions and comments and look forward to hearing from you. Please plan to attend.
|
Notables The Molecular Virology and Cancer Immunology Research Programs recently held a joint retreat in the Anlyan Center to highlight current research projects within the programs and to focus on collaborations between laboratories. Thank you to all who participated and attended the event. There were 28 submissions to the poster contest, congratulations to the following winners for their excellent work:
Roshan Karki The Kaposi's sarcoma-associated herpesvirus E3 ubiquitin ligase K5 acts as a novel oncogene, altering cellular metabolism and signaling: implications for tumorigenesis
Elizabeth Harker Scheideman Small Artificial Transmembrane Protein Inhibitors of CCR5 Function
Kathryn Juchem A Repertoire Independent and Cell Intrinsic Defect in GVHD Induction by Effector Memory T Cells
Eran Elinav Inflammation-induced Tumorigenesis in the Colon is Regulated by Caspase-1 and NLRC4 |
Newly Opened Clinical Trials HIC 1009007346 Principal Investigator: Jeffrey Weinreb, MD A Prospective, Multicenter Comparison of Multiphase Contrast-Enhanced CT and Multiphase Contrast-Enhanced MRI for Diagnosis of Hepatocellular Carcinoma and Liver Transplant Allocation HIC 1012007780 Principal Investigator: Melinda Irwin, PhD Lifestyle, Exercise and Nutrition (LEAN) Study HIC 1008007203 Principal Investigator: James Yu, MD A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with Rising PSA after Radical Prostatectomy HIC 1010007581 Principal Investigator: Howard Hochster, MD A randomized Phase II Study of Irinotecan and Cetuximab with or without the Anti-Angiogenic Antibody, Ramucirumab (IMC-1121B), in Advanced, K-ras Wild-type Colorectal Cancer Following Progression on Bevacizumab-Containing Chemotherapy |
Funding Opportunities Brozman Foundation Fellowship The Brozman Foundation will provide a Yale faculty member with funding to support/recruit a post-doctoral fellow to conduct research in ovarian cancer early detection and/or ovarian cancer prevention under the guidance of the Yale faculty member. This is a wonderful opportunity for faculty conducting research in ovarian cancer detection and/or prevention to further their work while training the next generation of researchers. Please contact Susan Mayne. Application Deadline:March 21, 2011.
The Harold Amos Medical Faculty Development Program A program of the Robert Wood Johnson Foundation, the Harold Amos Medical Faculty Development Program is now accepting applications for four-year postdoctoral research awards. These awards are available to physicians from historically disadvantaged backgrounds (ethnic, financial or educational) who are committed to pursuing careers in academic medicine, as well as to serving as role models for students and faculty of similar backgrounds. During the 2011 grant cycle, the program will offer up to eight four-year research awards in biomedical research, clinical investigation, and health services research and epidemiology. Scholars will receive an annual stipend of up to $75,000 each and a $30,000 annual grant to support research activities. Application Deadline: March 16, 2011
|
Recent Publications
Molecular basis for enhancement of the meiotic DMC1 recombinase by RAD51 associated protein 1 (RAD51AP1). Dray E, Dunlop MH, Kauppi L, Filippo JS, Wiese C, Tsai MS, Begovic S, Schild D, Jasin M, Keeney S, Sung P.
Proc Natl Acad Sci U S A. 2011 Feb 9.
Read More >>
Ovarian cancer stem cells and inflammation. Mor G, Yin G, Chefetz I, Yang Y, Alvero A.
Cancer Biol Ther. 2011 Apr 15;11(8).
Read More >>
Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival. Moran MS, Gonsalves L, Goss DM, Ma S.
Breast Cancer Res Treat. 2011 Feb 8.
Read More >>
Activation of the aryl hydrocarbon receptor by doxorubicin mediates cytoprotective effects in the heart. Volkova M, Palmeri M, Russell KS, Russell RR.
Cardiovasc Res. 2011 Feb 2.
Read More >>
Ocular neoplastic disease. Mahajan A, Crum A, Johnson MH, Materin MA.
Semin Ultrasound CT MR. 2011 Feb;32(1):28-37.
Read More >>
Pseudointraductal papillary mucinous neoplasia caused by microscopic periductal endocrine tumors of the pancreas: a report of 3 cases. Kenney B, Singh G, Salem RR, Paterno F, Robert ME, Jain D.
Hum Pathol. 2011 Feb 1.
Read More >>
A significant decrease in rectal volume and diameter during prostate IMRT. Anderson NS, Yu JB, Peschel RE, Decker RH.
Radiother Oncol. 2011 Jan 24.
Read More >>
Ipilimumab: a promising immunotherapy for melanoma. Thumar JR, Kluger HM.
Oncology (Williston Park). 2010 Dec;24(14):1280-8.
Read More >>
Evaluation of Vascular Endothelial Growth Factor as a Prognostic Marker for Local Relapse in Early-Stage Breast Cancer Patients Treated with Breast-Conserving Therapy. Moran MS, Yang Q, Goyal S, Harris L, Chung G, Haffty BG.
Int J Radiat Oncol Biol Phys. 2010 Nov 17.
Read More >>
Ductal Carcinoma In Situ with Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation. Parikh RR, Haffty BG, Lannin D, Moran MS.
Int J Radiat Oncol Biol Phys. 2010 Oct 13.
Read More >>
Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation. Bugger H, Guzman C, Zechner C, Palmeri M, Russell KS, Russell RR 3rd.
Cancer Chemother Pharmacol. 2010 Aug 31.
Read More >>
|
| |
| Countdown to the CCSG Submission 462 days until our CCSG grant
is due on May 25, 2012.
|
Inside Yale Cancer Center
ASCO Connection Read Anees Chagpar's latest blog on health reform. In the News Read recent articles featuring experts from Yale Cancer Center Learn More >>
Subscribe to Yale Cancer Center Answers on iTunes
Yale Cancer Center's weekly radio program on CT Public Radio is ranked number 2 in the world for cancer programs on iTunes. Subscribe to the show.
Learn More >>
Cancer Bytes
Hosted by Ellen Matloff, listen to the latest interview with Cindy: Surgical Menopause, BRCA Mutations and the Definition of Luck Learn More >> Yale Cancer Center Grand Rounds Video presentations from Yale Cancer Center members are now available online.
Learn More >> DirectConnect Archives
Learn More >>
|
Events February 18; 1:00 PM Developmental Therapeutics Seminar SHM I-116 Early Phase Clinical Trials Evaluating mTOR Inhibitors in Combination With Standard Systemic Therapies for the Treatment of Breast and Gynecologic Malignancies Maysa Abu-Khalaf, MD Learn More >> February 20; 6:00 PM Yale Cancer Center Answers WNPR Lung Cancer Daniel Morgensztern, MD Learn More >> February 21; 3:30 PM Signal Transduction Seminar SHM I-116 Single Cell Technology and Signaling Networks Rong Fan, PhD Learn More >> February 22; 12:00 PM Yale Cancer Center Grand Rounds 55 Park Street Uveal Melanoma Miguel Materin, MD Genomic Technologies Available at the Yale Center for Genome Analysis and Their Applications for Biomedical Research Shrikant Mane, PhD Learn More >> February 23; 12:00 PM Cancer Prevention and Control Seminar LEPH 216 Epidemiology of Thyroid Cancer Yawei Zhang, MD, MPH, PhD Learn More >> February 27; 6:00 PM Yale Cancer Center Answers WNPR Treatment with Ontak Jack Murphy, MD Learn More >> March 1; 12:00 PM Yale Cancer Center Grand Rounds 55 Park Street Targeted Therapy for Melanoma: BRAF Inhibitors and Nanoparticle-siRNA Antoni Ribas, PhD Learn More >> March 4; 10:00 AM Hematology Symposium
Honoring Dr. Bernard Forget
55 Park Street A Panel of Distinguished Lecturers Learn More >>
|
New Faculty Recruits (May 2009 - Present) Anees Chagpar Surgical Oncology Lieping Chen Immunobiology
Deborah Chirnomas Pediatric Oncology Leonard Farber Medical Oncology Mark Faries Surgical Oncology Valentina Greco Genetics Roy Herbst Medical Oncology Howard Hochster Medical Oncology Erin Hofstatter Medical Oncology Nina Horowitz Surgical Oncology Michael Hurwitz Medical Oncology Benjamin Judson Otolaryngology
Arthur Levy Medical Oncology Miguel Materin Ophthalmology Daniel Morgensztern Medical Oncology Don Nguyen Pathology Abhijit Patel Therapeutic Radiology Nikolai Podoltsev Hematology
Katie Politi Pathology Tara Sanft Medical Oncology Stacey Stein Medical Oncology Narendra Wajapeyee Pathology Qin Yan Pathology |
Submissions Please submit your recent publication and grant announcements to: Renee Gaudette Director, Public Affairs and Marketing
renee.gaudette@yale.edu
|
|
|
